SIK inhibitor for use in a method of treating an inflammatory and/or immune disorder

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9670165
SERIAL NO

14385077

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the discovery that salt inducible kinases (SIKs) suppress the formation of anti-inflammatory molecules such as IL-10, which are important for the resolution of inflammation and identifies SIK inhibitors that may be used to treat disorders associated with undesirable inflammation, such as inflammatory bowel disease and/or autoimmune disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE11 PERTH ROAD DUNDEE DD1 4HN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Choi, Hwan Geun Chestnut Hill, US 69 786
Clark, Kristopher Dundee, GB 2 64
Cohen, Philip Dundee, GB 27 134
Gray, Nathanael Boston, US 49 824

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 6, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00